Skip to main navigation
Allogene Therapeutics
Contact Us
Careers
SHARE
Email Us
Print
Allogene Therapeutics
  • Pipeline
    • AlloCAR T Product Pipeline
    • THE ALPHA3 TRIAL
    • THE RESOLUTION TRIAL
    • DATABRIEF
    • Expanded Access
  • Science
    • Next Revolution in Cell Therapy
    • Platform for Tomorrow
    • On-demand Availability
    • SCIENTIFIC PUBLICATIONS
  • About Us
    • At A Glance
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Partners
    • Corporate Responsibility
  • News Center
    • Press Releases
    • Events
    • Perspectives
    • Social Media
    • Community Guidelines
  • INVESTORS
    • IR Overview
    • News & Events
      • Press Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • Corporate Governance
      • Documents and Charters
      • Board of Directors
      • Management
      • Committee Composition
    • SEC Filings
    • Resources
      • Investor FAQs
      • Email Alerts
      • IR Inquiry

Press Release

Pfizer and Allogene Therapeutics Enter Into Asset Contribution Agreement for Pfizer’s Allogeneic CAR T Immuno-oncology Portfolio

Apr 3, 2018 at 8:00 AM EDT
Pfizer and Allogene Therapeutics Enter Into Asset Contribution Agreement for Pfizer’s Allogeneic CAR T Immuno-oncology Portfolio 339.9 KB
Print Page
Email Alerts
RSS Feeds
Investor Contacts
Facebook
Twitter
LinkedIn
E-Mail
Tumblr
Reddit
WhatsApp
Telegram
Allogene Therapeutics
CONNECT

210 E. Grand Avenue
South San Francisco, CA 94080

View Map / Contact Us

  • Pipeline
  • AlloCAR T Product Pipeline
  • THE ALPHA3 TRIAL
  • THE RESOLUTION TRIAL
  • DATABRIEF
  • Expanded Access
  • Science
  • Next Revolution in Cell Therapy
  • Platform for Tomorrow
  • On-Demand Availability
  • Scientific Publications
  • About Us
  • At a Glance
  • Management Team
  • Board of Directors
  • Scientific Advisors
  • Partners
  • Corporate Responsibility
  • News Center
  • Press Releases
  • Events
  • Perspectives
  • Social Media
  • Community Guidelines
  • Investors
  • Press Releases
  • Events
  • Presentations
  • Stock Information
  • Stock Quote & Chart
  • Historical Price Look Up
  • Investment Calculator
  • Corporate Governance
  • Documents & Charters
  • Board of Directors
  • Management
  • Committee Composition
  • SEC Filings
  • Resources
  • Investor FAQs
  • Email Alerts
  • IR Inquiry
©2026 Allogene Therapeutics
TERMS OF USE
PRIVACY NOTICE